Subscribe

News
Academy
Multimedia
Conferences
Publications
Partner Perspectives
Resources
Event Calendar
Subscribe

|Articles|November 26, 2007

Pharmaceutical Executive

Pharmaceutical Executive-11-28-2007
Volume 0
Issue 0

Test

Author(s)Matthew Herman

TKTKTKTKTKTK

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Related Content

stock.adobe.com DNA strand

FDA Grants Emergency Use Authorization for Seegene’s Multiplex PCR Assay

ByNicholas Jacobus

July 21st 2026

Gurinder S. Sidhu, M.D.

Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.

ByNicholas Jacobus,Gurinder S. Sidhu, MD

July 21st 2026

David Hung

Developing Better Drugs, Not Just More Drugs: Q&A with David Hung

ByMike Hollan,David Hung

July 21st 2026

Scott Warren

A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims

July 21st 2026

Gerren McHam, vice president of Government and External Affairs, API Innovation Center

What Policy Tools Move the Needle on API Manufacturing Capacity?

ByNicholas Jacobus,Gerren McHam

July 21st 2026

Trending on PharmExec

How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?

Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia

Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory

Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D

FDA Clears Consano’s IND for C-1101